| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |